Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
For a full list of topics: A-Z Index
Advanced Search
Advanced Search
Reproductive Health
    CDC Home
    • Facebook
    • Twitter
    • LinkedIn
    • Syndicate

    Appendix F: Management of Intrauterine Devices When Users are Found To Have Pelvic Inflammatory Disease*

    Minus
    Pages in this Report
    1. US SPR 2016
    2. Introduction
    3. How To Be Reasonably Certain that a Woman Is Not Pregnant
    4. Intrauterine Contraception
    5. Implants
    6. Injectables
    7. Combined Hormonal Contraceptives
    8. Progestin-Only Pills
    9. Standard Days Method
    10. Emergency Contraception
    11. Female Sterilization
    12. Male Sterilization
    13. When Women Can Stop Using Contraceptives
    14. Conclusion
    15. References
    16. Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
    17. When To Start Using Specific Contraceptive Methods
    18. Examinations and Tests Needed Before Initiation of Contraceptive Methods
    19. Routine Follow-Up After Contraceptive Initiation
    20. Management of Women with Bleeding Irregularities While Using Contraception
    21. Management of Intrauterine Devices When Users are Found To Have Pelvic Inflammatory Disease
    22. Participants
    Minus
    Related Pages
    Appendix F shows a flow chart describing the management of an intrauterine device when a woman using a copper-containing IUD or a levonorgestrel-releasing IUD is found to have pelvic inflammatory disease.

    Abbreviations: IUD = intrauterine device; PID = pelvic inflammatory disease.

    * Treat according to CDC’s STD Treatment Guidelines (available at https://www.cdc.gov/std/treatment).

    • PrevManagement of Wom...
    • NextParticipants

     

    Page last reviewed: February 1, 2017
    Content source: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion
    home CDC Contraceptive Guidance for Health Care Providers
    • US Selected Practice Recommendations for Contraceptive Use, 2016 expand
      • Table of Contents expand
        • Summary
        • Introduction
        • How To Be Reasonably Certain that a Woman Is Not Pregnant
        • Intrauterine Contraception
        • Implants
        • Injectables
        • Combined Hormonal Contraceptives
        • Progestin-Only Pills
        • Standard Days Method
        • Emergency Contraception
        • Female Sterilization
        • Male Sterilization
        • When Women Can Stop Using Contraceptives
        • Conclusion
        • References
        • Appendix A: Summary Chart of U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
        • Appendix B: When To Start Using Specific Contraceptive Methods
        • Appendix C: Examinations and Tests Needed Before Initiation of Contraceptive Methods
        • Appendix D: Routine Follow-Up After Contraceptive Initiation
        • Appendix E: Management of Women with Bleeding Irregularities While Using Contraception
        • Appendix F: Management of Intrauterine Devices When Users are Found To Have Pelvic Inflammatory Disease
        • Participants

     

     

    HAVE QUESTIONS?
    Visit CDC-INFO
    Call 800-232-4636
    Email CDC-INFO
    Open 24/7
    CDC INFORMATION
    • About CDC
    • Jobs
    • Funding
    • Policies
    • File Viewers & Players
    • Other Languages
    • Privacy
    • FOIA
    • No Fear Act
    • OIG
    • Nondiscrimination
    • Accessibility
    • Vulnerability Disclosure Policy | Español
    CONNECT WITH CDC
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Snapchat

    • Youtube
    • Syndicate
    • CDC TV
    • RSS
    • Email
    CONTACT CDC
    Visit CDC-INFO
    Call 800-232-4636
    Email CDC-INFO
    Open 24/7
    ABOUT CDC
    • About CDC
    • Jobs
    • Funding
    POLICIES
    • Policies
    • File Viewers & Players
    • Other Languages
    • Privacy
    • FOIA
    • No Fear Act
    • OIG
    • Nondiscrimination
    • Accessibility
    • Vulnerability Disclosure Policy | Español
    • CDC Website Exit Disclaimer external icon
    LANGUAGE ASSISTANCE
    • Español
    • 繁體中文
    • Tiếng Việt
    • 한국어
    • Tagalog
    • Русский
    • العربية
    • Kreyòl Ayisyen
    • Français
    • Polski
    • Português
    • Italiano
    • Deutsch
    • 日本語
    • فارسی
    • English
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Snapchat
    • Youtube
    • Syndicate
    • CDC TV
    • RSS
    • Email
    U.S. Department of Health & Human Services
    USA.gov
    CDC Website Exit Disclaimer external icon
    • Facebook
    • Twitter
    • LinkedIn

    Exit Notification / Disclaimer Policy

    Links with this icon indicate that you are leaving the CDC website.
    • The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
    • Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
    • You will be subject to the destination website's privacy policy when you follow the link.
    • CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
    For more information on CDC's web notification policies, see Website Disclaimers.